Patterns and determinants of receipt of follow-up mammography and/or clinical examination in a cohort of Italian breast cancer survivors
Tóm tắt
Information regarding the use of mammography by breast cancer survivors is limited. This study aimed at evaluating the compliance to surveillance mammography and/or clinical breast examination and the associated factors among patients living in northern Italy. A cancer registry-based cohort of 1304 patients living in the Health Care District of Forlì was followed up for 10 years. Eighty percent of patients had a mammogram and/or clinical breast examination during the first year after treatment. The proportion decreased to 67 % at 10 years of follow-up. Three demographic characteristics were independently associated with lower odds of having an annual mammogram and/or clinical breast examination: age at diagnosis [odds ratio (OR) 0.51, 95 % confidence interval (CI) 0.41–0.63 for patients aged 65–74 years; and OR 0.14, 95 % CI 0.11–0.18, for patients ≥75 years versus patients aged <64 year]; socio-economic status (OR 0.81, 95 % CI 0.65–1.00, for deprived patients versus patients of the reference class); and hospital travel time greater than 30 min (OR 0.44, 95 % CI 0.29–0.68 versus ≤15 min). With respect to clinical and disease characteristics, lower odds were observed for patients treated with mastectomy (OR 0.79, 95 % CI 0.65–0.97), for patients diagnosed with in situ breast cancer (OR 0.68, 95 % CI 0.46–0.99) as well as with stage II + breast cancer (OR 0.77, 95 % CI 0.63–0.94), and for patients with ≥3 Elixhauser comorbidities (OR 0.43, 95 % CI 0.26–0.71). Adherence to follow-up declined over time. Knowledge of associated factors may assist in improving access to care for breast cancer survivors.
Tài liệu tham khảo
Grunfeld E, Noorani H, McGahan L et al (2002) Surveillance mammography after treatment of primary breast cancer: a sistematic review. Breast 11:228–235
Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, Pacini P (1999) Intensive vs clinical follow up after treatment of primary breast cancer: 10 year update of a randomized trial: national research council project on breast cancer follow up. JAMA 281:1586
Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V (1994) Intensive vs clinical follow up after treatment of primary breast cancer: 10 years update of a randomized trial: national research council project on breast cancer follow up. JAMA 271(20):1593–1597
Foncam (Forza operativa Cancro della Mammella) guidelines http://www.senologia.it/images/pdf/LG_cap13.pdf Accessed 20 Dec 2012
The Givio investigators (1994) Impact of follow up testing on survival and heakth-related quality of life in breast cancer patient. A multicenter randomized controlled trial. JAMA 271(20):1587–1592
Houssami N, Ciatto S, Martinelli F, Bonardi R, Duffy SW (2009) Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol 20(9):1505–1510
Houssami N, Ciatto S (2010) Mammographic surveillance in women with a personal history of breast cancer: how accurate? how effective? Breast 19(6):439–445
Robinson A, Speers C et al (2007) Method of detection of new contralateral primary breast cancer in younger versus older women. Clin Breast Cancer 7:705–709
Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE (2013) Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. American Society of Clinical Oncology. J Clin Oncol 31(7):961–965
Kataja V, Castiglione M (2009) Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow up. Ann Oncol 20(Suppl 4):10–14
Rudgers EJ Th (2006) Quality control in the locoregional treatment of breast cancer. In: European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. pp 323–334
Perry NM (2006) Multidisciplinary aspects of quality assurance in the diagnosis of breast disease. In: European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. pp 197–217
Schapira MM, McAuliffe TL, Nattinger AB (2000) Underutilization of mammography in older breast cancer survivors. Med Care 38:281–289
Doubeni CA, Field TS, Ulcickas Yood M, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F (2006) Patterns and predictors of mammography utilization among breast cancer survivor. Cancer 106(11):2482–2488
Field TS, Doubeni C, Fox MP, Buist DS, Wei F, Geiger AM, Quinn VP, Lash TL, Prout MN, Yood MU, Frost FJ, Silliman RA (2008) Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med 23(2):158–163
Etim AE, Schellhase KG, Sparapani R, Nattinger AB (2006) Effect of model of care delivery on mammography use among elderly breast cancer survivors. Breast Cancer Res Treat 96:293–299
Carcaise-Edinboro P, Bradley CJ, Dahman B (2010) Surveillance mammography for medicaid/medicare breast cancer patients. J Cancer Surviv 4(1):59–66
Khan NF, Carpenter L, Watson E, Rose PW (2010) Cancer screening and Preventive care among long term cancer survivors in the United Kingdom. Br J Cancer 102(7):1085–1090
Onega T, Cook A, Kirlin B, Shi X, Alford-Teaster J, Tuzzio L, Buist DS (2011) The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat 129(1):269–275
Wirtz HS, Boudreau DM, Gralow JR, Barlow WE, Gray S, Bowles EJ, Buist DS (2014) Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors. Breast Cancer Res Treat 143(3):541–550
AIRTUM Working Group (2014) Italian cancer figures, report 2014: prevalence and cure of cancer in Italy. Epidemiol Prev 38:1–122
De Lena M, Fergurson J, Liberati A (1995) Consensus conference on follow up in breast cancer. Elected papers. Ann Oncol 6(2):1–70
Caranci N, Biggeri A, Grisotto L, Pacelli B, Spadea T, Costa G (2010) L’indice di deprivazione italiano a livello di sezione di censimento: definizione, descrizione e associazione con la mortalità. Epidemiol Prev 34:167–176
Puliti D, Miccinesi G, Manneschi G, Buzzoni C, Crocetti E, Paci E, Zappa M (2012) Does an organised screening programme reduce the inequalities in breast cancer survival. Ann Oncol 23(2):319–323
Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36(1):8–27
Hube Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130
Chiusolo M, Cadum E, Stafoggia M, Galassi C, Berti G, Faustini A, Bisanti L, Vigotti MA, Dessì MP, Cernigliaro A, Mallone S, Pacelli B, Minerba S, Simonato L, Forastiere F (2011) EpiAir collaborative group. Short term effects of nitrogen dioxide on mortality and susceptibility factors in ten Italian cities: the EpiAir study. Environ Health Perspect 119(9):1233–1238
Montgomery DA, Krupa K, Cooke TG (2007) Follow-up in breast cancer: does routine clinical examination improve outcome? a systematic review of the literature. Br J Cancer 97(12):1632–1641
Pivot X, Asmar L, Hortobagyi GN, Theriault R, Pastorini F, Buzdar A (2000) A retrospective study of first indicators of breast cancer recurrence. Oncology 58(3):185–190
Van den Akker M, Buntinx F, Metsemakers JF, Roos S, Knottnerus JA (1998) Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemio 51:367–375